Could a Two-Drug combo supercharge weight loss?
NCT ID NCT06373146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding a second drug (mibavademab) to the weight-loss medication tirzepatide helps adults with obesity lose more weight than tirzepatide alone. About 392 participants with a BMI between 30 and 40 took part. The goal was to measure changes in body weight over 74 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
Hassman Research Institute Marlton Site
Marlton, New Jersey, 08053, United States
-
Irvine Clinical Research
Irvine, California, 92614, United States
-
Juno Research
Houston, Texas, 77040, United States
-
Lillestol Research
Fargo, North Dakota, 58104, United States
-
Northwest Clinical Research Center
Bellevue, Washington, 98007, United States
-
Solaris Clinical Research
Meridian, Idaho, 83646, United States
-
South Texas Clinical Research
Corpus Christi, Texas, 78404, United States
-
Tandem Clinical Research
Marrero, Louisiana, 70072, United States
-
Velocity Clinical Research - New Orleans
New Orleans, Louisiana, 70119, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Velocity Clinical Research, Gardena
Gardena, California, 90247, United States
-
Velocity Clinical Research, Los Angeles
Los Angeles, California, 90017, United States
-
Velocity Clinical Research, North Hollywood
North Hollywood, California, 91606, United States
-
Velocity Clinical Research, Panorama City
Van Nuys, California, 91405, United States
-
Velocity Clinical Research, Santa Ana
Santa Ana, California, 92704, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?